Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation

Peter Johann, Chief Executive Officer of Lumendi, noted, "Our products are designed to provide an edge in tackling the complexities of polypectomies, thereby improving patient outcomes and delivering higher curative rates. That said, the positive customer response to the DiLumen EZ is a testament to our commitment, and our ability to deliver transformative solutions for challenging gastrointestinal interventions."

Continue ReadingLumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation